---
layout: post
title: Omics and Personalised Healthcare - February 2012
date: '2011-12-21T11:25:00.001Z'
author: John Overington
tags:
- Conferences
modified_time: '2011-12-21T11:25:42.048Z'
thumbnail: http://1.bp.blogspot.com/-pzl96AB4pmg/TvHBtVLIKDI/AAAAAAAABd0/cZFF9tfAkgw/s72-c/PRO12-01-Banner.jpg
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-8001570449505630375
blogger_orig_url: http://chembl.blogspot.com/2011/12/omics-and-personalised-healthcare.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-pzl96AB4pmg/TvHBtVLIKDI/AAAAAAAABd0/cZFF9tfAkgw/s1600/PRO12-01-Banner.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://1.bp.blogspot.com/-pzl96AB4pmg/TvHBtVLIKDI/AAAAAAAABd0/cZFF9tfAkgw/s1600/PRO12-01-Banner.jpg" /></a></div>
<br />
We're speaking at the forthcoming <a href="http://www.embl.de/training/events/2012/PRO12-01/PRO12-01-Poster.pdf">EMBL Conference on Omics and Personalised Healthcare</a>&nbsp;in Heidelberg, held 16th to 18th February 2012. We'll present some of our recent work on pharmacogenetic variation, and some strategies on both data-mining and some of the implications for drug discovery.